Assays

These assays leverage the precision of PCR (Polymerase Chain Reaction) technology to amplify and scrutinize specific DNA segments. This process is pivotal in identifying genetic variations that influence how patients metabolize and respond to medications. By providing insights into individual genetic profiles, these assays play a crucial role in the development of personalized medicine strategies. They are instrumental in ensuring that patients receive the most effective and safe medication regimens, tailored to their unique genetic makeup, thereby optimizing therapeutic outcomes. Goffin supplies pharmacogenetic assays for DPYD, TPMT, MTHFR and related genes that guide drug-dosing decisions.